Effects of Intensive Upper and Lower Limbs Motor Control Therapy in Cerebral Palsy Children
Overview
The aim of the study is to determine the effetiveness of the intensive upper and lower limbs therapy to improve the funtional outcomes and to minimize ther energetic spendings during funtional activities in Cerebral Palsy patients.
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: Double (Participant, Outcomes Assessor)
- Study Primary Completion Date: August 3, 2017
Detailed Description
The aim of the study is to determine the effetiveness of the intensive upper and lower limbs therapy to improve the funtional outcomes and to minimize ther energetic spendings during funtional activities in Cerebral Palsy patients. Also to know paretns and caregivers perceptions.
Interventions
- Other: Intensive bimanual therapy
- Ninety hours of intensive bimanual therapy
- Other: Intensive neurodevelopmental therapy
- Ninety hours of intensive neurodevelopmental therapy
Arms, Groups and Cohorts
- Experimental: Intensive bimanual therapy
- Ninety hours of intensive bimanual therapy
- Active Comparator: Neurodevelopmental treatment
- Ninety hours of intensive neurodevelopmental therapy
Clinical Trial Outcome Measures
Primary Measures
- Arm Funtion
- Time Frame: 6 months
- Assissting Hand Assessment Instrument (AHA)
Secondary Measures
- Funtional Activity
- Time Frame: 6 months
- Jebsen Taylor Hand Funtion Test
- Perception of performance in everyday living
- Time Frame: 6 months
- Canadian Occupational Performance Measure (COMP)
Participating in This Clinical Trial
Inclusion Criteria
- Cerebral Palsy Exclusion Criteria:
-
Gender Eligibility: All
Minimum Age: 6 Years
Maximum Age: 12 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- University of Alcala
- Collaborator
- European University Spain
- Provider of Information About this Clinical Study
- Principal Investigator: Isabel Rodriguez Costa, PhD – University of Alcala
- Overall Official(s)
- Andrew Gordon, PhD, Study Director, Columbia Universuty
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.